Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer

Authors: Forde, Patrick M, Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M, Felip, Enriqueta, Broderick, Stephen R, Brahmer, Julie R, Swanson, Scott J, Kerr, Keith, Wang, Changli, Ciuleanu, Tudor–Eliade, Saylors, Gene B, Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke Neng, Liberman, Moishe, Vokes, Everett E, Taube, Janis M, Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y, Girard, Nicolas

Source: Future oncology. 19(8):549-557

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100189952085.0x000001&indx=1&recIds=ETOCvdc_100189952085.0x000001

Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design

Authors: Khushalani, Nikhil I, Diab, Adi, Ascierto, Paolo A, Larkin, James, Sandhu, Shahneen, Sznol, Mario, Koon, Henry B, Jarkowski, Anthony, Zhou, Ming, Statkevich, Paul, Geese, William J, Long, Georgina V

Source: Future oncology. 16(28):2165-2175

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186989576.0x000001&indx=1&recIds=ETOCvdc_100186989576.0x000001

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Authors: Zandberg, Dan P., Algazi, Alain P., Jimeno, Antonio, Good, James S., Fayette, Jérôme, Bouganim, Nathaniel, Ready, Neal E., Clement, Paul M., Even, Caroline, Jang, Raymond W., Wong, Stuart, Keilholz, Ulrich, Gilbert, Jill, Fenton, Moon, Braña, Irene, Henry, Stephanie, Remenar, Eva, Papai, Zsuzsanna, Siu, Lillian L., Jarkowski, Anthony, Armstrong, Jon M., Asubonteng, Kobby, Fan, Jean, Melillo, Giovanni, Mesía, Ricard

Source: In European Journal of Cancer January 2019 107:142-152

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

Authors: Blumenthal, Gideon M., Bunn, Paul A., Jr., Chaft, Jamie E., McCoach, Caroline E., Perez, Edith A., Scagliotti, Giorgio V., Carbone, David P., Aerts, Hugo J.W.L., Aisner, Dara L., Bergh, Jonas, Berry, Donald A., Jarkowski, Anthony, Botwood, Nicholas, Cross, Darren A.E., Diehn, Max, Drezner, Nicole L., Doebele, Robert C., Blakely, Collin M., Eberhardt, Wilfried E.E., Felip, Enriqueta, Gianni, Luca, Keller, Steven P., Leavey, Patrick J., Malik, Shakun, Pignatti, Francesco, Prowell, Tatiana M., Redman, Mary W., Rizvi, Naiyer A., Rosell, Rafael, Rusch, Valerie, de Ruysscher, Dirk, Schwartz, Lawrence H., Sridhara, Rajeshwari, Stahel, Rolf A., Swisher, Stephen, Taube, Janis M., Travis, William D., Keegan, Patricia, Wiens, Jacinta R., Wistuba, Ignacio I., Wynes, Murry W., Hirsch, Fred R., Kris, Mark G.

Source: In Journal of Thoracic Oncology December 2018 13(12):1818-1831

Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)

Authors: Jarkowski, Anthony, Hare, Ryan, Loud, Peter, Skitzki, Joseph J., Kane, John M., May, Kilian S., Zeitouni, Nathalie C., Nestico, Jill, Vona, Karen L., Groman, Adrienne, Khushalani, Nikhil I.

Source: American journal of clinical oncology. 39(6):545-548

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100038209691.0x000001&indx=1&recIds=ETOCvdc_100038209691.0x000001

Retrospective Analysis of the Safety and Efficacy of High-dose Interleukin-2 After Prior Tyrosine Kinase Inhibitor Therapy in Patients With Advanced Renal Cell Carcinoma

Authors: Lam, Elaine T., Wong, Michael K. K., Agarwal, Neeraj, Redman, Bruce G., Logan, Theodore, Gao, Dexiang, Flaig, Thomas W., Lewis, Karl, Poust, Jamie, Monk, Paul, Jarkowski, Anthony, Sendilnathan, Arun, Bolden, Marcus, Kuzel, Timothy M., Olencki, Thomas

Source: Journal of immunotherapy. 37(7):360-365

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCETOCvdc_100030236677.0x000001&indx=1&recIds=ETOCETOCvdc_100030236677.0x000001

Immunotherapy in Melanoma: Recent Advances and Promising New Therapies

Authors: Saraceni, Megan M., Khushalani, Nikhil I., Jarkowski, Anthony

Source: Journal of pharmacy practice. 28(2):193-203

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN600597642&indx=1&recIds=ETOCRN600597642

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.

Authors: Siu, Lillian L., Even, Caroline, Mesía, Ricard, Remenar, Eva, Daste, Amaury, Delord, Jean-Pierre, Krauss, Jürgen, Saba, Nabil F., Nabell, Lisle, Ready, Neal E., Braña, Irene, Kotecki, Nuria, Zandberg, Dan P., Gilbert, Jill, Mehanna, Hisham, Bonomi, Marcelo, Jarkowski, Anthony, Melillo, Giovanni, Armstrong, Jon M., Wildsmith, Sophie

Source: JAMA Oncology; Feb2019, Vol. 5 Issue 2, p195-203, 9p

BRAF and beyond: Tailoring strategies for the individual melanoma patient

Authors: Jarkowski, Anthony, Khushalani, Nikhil

Source: Journal of carcinogenesis. 13(1):1-1

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100092046625.0x000001&indx=1&recIds=ETOCvdc_100092046625.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A new era for castrate resistant prostate cancer: A treatment review and update.

Authors: Fong, Mei Ka, Hare, Ryan, Jarkowski, Anthony

Source: Journal of Oncology Pharmacy Practice; Sep2012, Vol. 18 Issue 3, p343-354, 12p, 2 Charts

Subject Terms: DRUG therapy, HORMONE therapy, ADRENOCORTICAL hormones, ANTINEOPLASTIC agents, KETOCONAZOLE, NITROGEN mustards, PROSTATE tumors treatment, SYNTHETIC progestagens, MITOXANTRONE, CLINICAL trials, GONADOTROPIN, LUTEINIZING hormone releasing hormone, PROSTATE tumors, SURVIVAL, DISEASE progression, CANCER vaccines, CHEMICAL inhibitors, VACCINES, THERAPEUTICS

Geographic Terms: UNITED States

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

Authors: Jarkowski, Anthony¹, Forrest, Alan², Sweeney, Richard P³, Tan, Wei⁴, Segal, Brahm H⁵, Almyroudis, Nikolaos⁵, Wang, Eunice S⁵, Wetzler, Meir⁵

Source: Journal of Oncology Pharmacy Practice. Mar2012, Vol. 18 Issue 1, p91-96. 6p. 5 Charts.

Subject Terms: *NEPHROTOXICOLOGY, *CANCER patients, *CANCER treatment, *CREATININE, *DRUG monitoring, *DOSE-effect relationship in pharmacology, *KIDNEYS, *PHARMACEUTICAL arithmetic, *SCALES (Weighing instruments), *TIME, *GRAM-positive bacterial infections, *VANCOMYCIN, *SPECIALTY hospitals, *MYELOID leukemia, *DESCRIPTIVE statistics, *STANDARDS, *PREVENTION

Geographic Terms: NEW York (State)

Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukemia – easier said than done? A case report.

Authors: Al-Najjar, Fouad (AUTHOR), Jarkowski, Anthony (AUTHOR)

Source: Journal of Oncology Pharmacy Practice. Dec2011, Vol. 17 Issue 4, p436-439. 4p.

URL: 67550453